The9 (NCTY) Research & Development (2009 - 2026)

The9 (NCTY) posted quarterly Research & Development of -$695.3 million for Q1 2026, down 2963.16% year-over-year from $24.3 million in Q1 2025, and down 3151.98% quarter-over-quarter from $22.8 million in Q2 2025.

The9 (NCTY) Research & Development (2009 - 2026) Analysis & Trends

The9's Research & Development history runs 14 years deep, the most recent figure standing at -$695.3 million for Q1 2026.

  • In Q1 2026, Research & Development fell 2963.16% year-over-year to -$695.3 million; the TTM figure through Mar 2026 stood at -$695.3 million (down 2895.31% YoY), while the FY2025 annual figure was $4.9 million, up 4049.57% from the prior year.
  • Research & Development for Q1 2026 stood at -$695.3 million, down from $22.8 million in the prior quarter.
  • The five-year high for Research & Development was $22.8 million in Q2 2025, with the low at -$695.3 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Morgan Stanley 338.83 Bn 205.30 Bn - 1.20 Bn
2 Goldman Sachs 316.34 Bn -660.01 Bn - 635.00 Mn
3 Schwab Charles 220.55 Bn 135.80 Bn - -
4 Futu Holdings 121.48 Bn 105.59 Bn 733.58 Mn -65.09 Mn
5 Robinhood Markets 84.07 Bn 66.74 Bn 1.20 Bn 256.00 Mn
6 Iren 68.17 Bn 65.95 Bn 104.86 Mn -
7 ATIF Holdings 45.42 Bn 45.42 Bn - -
8 Interactive Brokers 39.54 Bn -3.28 Bn - -
9 LPL Financial Holdings 28.27 Bn 25.57 Bn - 26.20 Mn
10 The9 49,552.00 -5.97 Mn 363.81 Mn -695.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -695.29 Mn
Jun 30, 2025 22.78 Mn
Mar 31, 2025 -22.70 Mn
Dec 31, 2020 -97,551.31
Dec 31, 2019 -300,009.58
Dec 31, 2018 -117,113.95
Dec 31, 2017 -551,849.69
Dec 31, 2016 -1.45 Mn
Dec 31, 2015 -2.55 Mn
Dec 31, 2014 -5.46 Mn
Dec 31, 2013 -2.74 Mn
Sep 30, 2013 -5.46 Mn
Jun 30, 2013 -6.14 Mn
Mar 31, 2013 -4.78 Mn
Dec 31, 2012 -6.59 Mn
Sep 30, 2012 -8.42 Mn
Jun 30, 2012 -7.05 Mn
Mar 31, 2012 -7.67 Mn
Dec 31, 2011 -4,250.06 Bn
Sep 30, 2011 -6,101.50 Bn